Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mind Medicine | CBOE Canada | Healthcare | Biotechnology & Medical Research | $850.63M | -2.8x | 0.08 | $14.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Cybin | CBOE Canada | Healthcare | Biotechnology & Medical Research | $300.09M | -1.5x | -0.97 | $0.39 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Fennec Pharma | Toronto | Healthcare | Biotechnology & Medical Research | $252.24M | 61.2x | 0.55 | $9.23 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Cardiol Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $214.90M | -6.7x | 14.98 | $3.13 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
NervGen Pharma | TSXV | Healthcare | Biotechnology & Medical Research | $201.09M | -5.9x | -1.23 | $2.85 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Medicenna | Toronto | Healthcare | Biotechnology & Medical Research | $168.72M | -5.9x | 0.04 | $2.22 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
ZEN Graphene | TSXV | Healthcare | Biotechnology & Medical Research | $136.66M | -11.6x | -0.72 | $1.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Eupraxia Pharmaceuticals | Toronto | Healthcare | Biotechnology & Medical Research | $124.68M | -2.2x | 0.12 | $3.70 | 5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Oncolytics Biotech | Toronto | Healthcare | Biotechnology & Medical Research | $109.89M | -3.6x | -1.16 | $1.44 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Arch Biopartners | TSXV | Healthcare | Biotechnology & Medical Research | $92.81M | -43.2x | -2.81 | $1.59 | 6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Zyus Life Sciences | TSXV | Healthcare | Biotechnology & Medical Research | $70.85M | -1.6x | -0.23 | $1 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Helix BioPharma Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $55.15M | -7.5x | -12.35 | $0.22 | -16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Satellos Bioscience | Toronto | Healthcare | Biotechnology & Medical Research | $53.60M | -2.4x | -0.09 | $0.47 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Covalon Technologies | TSXV | Healthcare | Biotechnology & Medical Research | $52.05M | -18.8x | -0.34 | $2.11 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
KDA Group | TSXV | Healthcare | Biotechnology & Medical Research | $49.14M | 4.4x | -0.01 | $0.28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Microbix Biosystems Inc. | Toronto | Healthcare | Biotechnology & Medical Research | $43.75M | 10.7x | 0.03 | $0.32 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
NurExone Biologic | TSXV | Healthcare | Biotechnology & Medical Research | $42.31M | -4.3x | -0.18 | $0.61 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
MustGrow Biologics | TSXV | Healthcare | Biotechnology & Medical Research | $39.76M | -71.9x | -0.65 | $0.78 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $38.25M | 0.05 | $0.81 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $38.25M | 0.05 | $0.81 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Thiogenesis Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $35.49M | -5.9x | 0.21 | $0.79 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Avicanna | Toronto | Healthcare | Biotechnology & Medical Research | $30.56M | -2.9x | -0.08 | $0.30 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Aeterna Zentaris | Toronto | Healthcare | Biotechnology & Medical Research | $22.96M | -0.4x | -0.04 | $7.50 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Briacell Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $19.20M | -2x | -0.03 | $1.05 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
BioMark Diagnostics Inc | CSE | Healthcare | Biotechnology & Medical Research | $19.10M | -13.6x | -0.45 | $0.23 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Kane Biotech | TSXV | Healthcare | Biotechnology & Medical Research | $18.55M | -3.4x | 0.15 | $0.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | $17.38M | -0.6x | -0.09 | $0.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | $17.38M | -0.6x | -0.09 | $0.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Aptose Biosciences | Toronto | Healthcare | Biotechnology & Medical Research | $16.91M | -0.1x | -0.01 | $0.77 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Biovaxys Technology | CSE | Healthcare | Biotechnology & Medical Research | $16.52M | -2x | -0.04 | $0.07 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |